Savara Inc. (SVRA) Q4 2018 Earnings Conference Call Transcript

NASDAQRead the rest “Savara Inc. (SVRA) Q4 2018 Earnings Conference Call Transcript”

Savara To Report Q4/Year-End 2018 Financial Results And Business Update On March 13, 2019

AccesswireRead the rest “Savara To Report Q4/Year-End 2018 Financial Results And Business Update On March 13, 2019”

Savara Announces Appointment of Peter Ginsberg as Vice President of Business Development

MarketWiredRead the rest “Savara Announces Appointment of Peter Ginsberg as Vice President of Business Development”

Savara Inc. (SVRA) Can’t Burn Your Long Portfolio. Just Reaches 52-Week High

BZ WeeklyRead the rest “Savara Inc. (SVRA) Can’t Burn Your Long Portfolio. Just Reaches 52-Week High”

Savara Added to Nasdaq Biotechnology Index

MarketWiredRead the rest “Savara Added to Nasdaq Biotechnology Index”

Savara Receives $5 Million Award From Cystic Fibrosis Foundation Therapeutics to Advance MRSA Cure

EquitiesRead the rest “Savara Receives $5 Million Award From Cystic Fibrosis Foundation Therapeutics to Advance MRSA Cure”

Savara nabs $5M award from CF nonprofit to support development of AeroVanc; shares up 4%

Seeking AlphaRead the rest “Savara nabs $5M award from CF nonprofit to support development of AeroVanc; shares up 4%”

Savara (SVRA) Secures $5M Award from Cystic Fibrosis Foundation Therapeutics Inc. for Development of AeroVanc

Street InsiderRead the rest “Savara (SVRA) Secures $5M Award from Cystic Fibrosis Foundation Therapeutics Inc. for Development of AeroVanc”

Savara Receives $5 Million Award From Cystic Fibrosis Foundation Therapeutics, Inc. for the Development of AeroVanc

SavaraRead the rest “Savara Receives $5 Million Award From Cystic Fibrosis Foundation Therapeutics, Inc. for the Development of AeroVanc”

Savara’s (SVRA) CEO Rob Neville on Q3 2017 Results – Earnings Call Transcript

Seeking AlphaRead the rest “Savara’s (SVRA) CEO Rob Neville on Q3 2017 Results – Earnings Call Transcript”

Savara Reports Third Quarter 2017 Financial Results and Provides Business Update

MarketWiredRead the rest “Savara Reports Third Quarter 2017 Financial Results and Provides Business Update”

Savara Raises $47 Million in Stock and Warrant Deal

Equities.comRead the rest “Savara Raises $47 Million in Stock and Warrant Deal”

Post-IPO Equity – Savara Pharmaceuticals

CrunchbaseRead the rest “Post-IPO Equity – Savara Pharmaceuticals”

Savara Announces Pricing of Public Offering of Common Stock

MarketWatchRead the rest “Savara Announces Pricing of Public Offering of Common Stock”

Savara Announces Expansion of Molgradex Development to Include Treatment of Nontuberculous Mycobacterial (NTM) Lung Infection

Digital JournalRead the rest “Savara Announces Expansion of Molgradex Development to Include Treatment of Nontuberculous Mycobacterial (NTM) Lung Infection”

Savara Announces Expansion of Molgradex Development to Include Treatment of Nontuberculous Mycobacterial (NTM) Lung Infection

Marketwired OnlineRead the rest “Savara Announces Expansion of Molgradex Development to Include Treatment of Nontuberculous Mycobacterial (NTM) Lung Infection”

Savara Starts Phase 3 Trial of AeroVanc for MRSA Lung Infections in Cystic Fibrosis

Cystic Fibrosis News TodayRead the rest “Savara Starts Phase 3 Trial of AeroVanc for MRSA Lung Infections in Cystic Fibrosis”

Savara Announces Start of Pivotal Phase III AVAIL Study of AeroVanc

Pipeline ReviewRead the rest “Savara Announces Start of Pivotal Phase III AVAIL Study of AeroVanc”

Savara launches late-stage study of AeroVanc in CF patients with MRSA lung infections

Seeking AlphaRead the rest “Savara launches late-stage study of AeroVanc in CF patients with MRSA lung infections”

Savara Announces Start of Pivotal Phase III AVAIL Study of AeroVanc

MarketWiredRead the rest “Savara Announces Start of Pivotal Phase III AVAIL Study of AeroVanc”

Savara to Present at the Cantor Fitzgerald 2017 Global Healthcare Conference on September 27th

MarketWiredRead the rest “Savara to Present at the Cantor Fitzgerald 2017 Global Healthcare Conference on September 27th”

Savara Reports Second Quarter 2017 Financial Results and Provides Business Update

MarketWiredRead the rest “Savara Reports Second Quarter 2017 Financial Results and Provides Business Update”

Savara’s Aironite shows treatment effect in mid-stage pulmonary hypertension study; shares ahead 4%

Seeking AlphaRead the rest “Savara’s Aironite shows treatment effect in mid-stage pulmonary hypertension study; shares ahead 4%”

Savara Set To Join Russell Microcap® Index

Cision PR NewswireRead the rest “Savara Set To Join Russell Microcap® Index”

Savara Announces Closing Of Public Offering Of Common Stock

GurufocusRead the rest “Savara Announces Closing Of Public Offering Of Common Stock”

Savara Announces Pricing Of Public Offering Of Common Stock

Cision PR NewswireRead the rest “Savara Announces Pricing Of Public Offering Of Common Stock”

Why Savara Inc (NASDAQ:SVRA) Is In Focus?

Financial TrendsRead the rest “Why Savara Inc (NASDAQ:SVRA) Is In Focus?”

Are Discerning Investors Interested in Savara Inc. (:SVRA)?

Evergreen CallerRead the rest “Are Discerning Investors Interested in Savara Inc. (:SVRA)?”

What You Should Know About Savara Inc (NASDAQ:SVRA)?

Financial TrendsRead the rest “What You Should Know About Savara Inc (NASDAQ:SVRA)?”

Savara Inc (NASDAQ:SVRA) Reported Accelerated U.S. Molgradex Development Plan

Financial TrendsRead the rest “Savara Inc (NASDAQ:SVRA) Reported Accelerated U.S. Molgradex Development Plan”

Savara Inc (SVRA) Is Preparing A Pivotal Phase-3 Study Of AeroVanc

Simply Wall StreetRead the rest “Savara Inc (SVRA) Is Preparing A Pivotal Phase-3 Study Of AeroVanc”

Savara Inc (NASDAQ:SVRA) Updates On U.S. Composition Of Matter Patent

Financial TrendsRead the rest “Savara Inc (NASDAQ:SVRA) Updates On U.S. Composition Of Matter Patent”

Tech Coast Angels Declares Record First Quarter; Angel Network Invests $3.8M in Q1 2017

For PR Web, click here

IRVINE, Calif. – May 11, 2017Tech Coast Angels (TCA) today announced that it had invested a total of $3.8 million in 17 total deals for the quarter ending March 31, 2017—its best Q1 in the angel network’s 20-year history both in dollars and number of companies invested.… Read the rest “Tech Coast Angels Declares Record First Quarter; Angel Network Invests $3.8M in Q1 2017”

Company with KU Roots Goes Public on NASDAQ

NewswiseRead the rest “Company with KU Roots Goes Public on NASDAQ”

BRIEF-Savara says will modify statistical analyses of its ongoing Impala study

ReutersRead the rest “BRIEF-Savara says will modify statistical analyses of its ongoing Impala study”

Savara (SVRA) Announces Expedited Molgradex Development Strategy Following Guidance from FDA

StreetInsider.comRead the rest “Savara (SVRA) Announces Expedited Molgradex Development Strategy Following Guidance from FDA”

Tech Coast Angels: How Savara Created A Winning Formula for Angel Investors and Company Success

PR WebRead the rest “Tech Coast Angels: How Savara Created A Winning Formula for Angel Investors and Company Success”

Savara Announces Issuance Of U.S. Composition Of Matter Patent Covering AeroVanc

PR NewswireRead the rest “Savara Announces Issuance Of U.S. Composition Of Matter Patent Covering AeroVanc”

SAVARA INC. (NASDAQ:SVRA) Files An 8-K Termination of a Material Definitive Agreement

Market ExclusiveRead the rest “SAVARA INC. (NASDAQ:SVRA) Files An 8-K Termination of a Material Definitive Agreement”

North Texas Angel Network Announces Portfolio Company Savara’s Transition to the Public Market

PR WebRead the rest “North Texas Angel Network Announces Portfolio Company Savara’s Transition to the Public Market”

Savara, Inc.’s Public Debut

Seeking AlphaRead the rest “Savara, Inc.’s Public Debut”

BRIEF-Savara says has entered into a loan agreement with silicon valley bank

ReutersRead the rest “BRIEF-Savara says has entered into a loan agreement with silicon valley bank”

Savara Secures $15 Million Loan And Security Agreement With Silicon Valley Bank

Yahoo! FinanceRead the rest “Savara Secures $15 Million Loan And Security Agreement With Silicon Valley Bank”

Savara Announces Closing Of Merger With Mast Therapeutics

Yahoo! FinanceRead the rest “Savara Announces Closing Of Merger With Mast Therapeutics”

Savara Announces Closing Of Merger With Mast Therapeutics

Crossroads TodayRead the rest “Savara Announces Closing Of Merger With Mast Therapeutics”

Savara Announces Closing Of Merger With Mast Therapeutics

PR NewswireRead the rest “Savara Announces Closing Of Merger With Mast Therapeutics”

Mast Therapeutics Inc (NYSEMKT:MSTX) And Savara Update On Expected Merger Exchange Ratio

Financial TrendsRead the rest “Mast Therapeutics Inc (NYSEMKT:MSTX) And Savara Update On Expected Merger Exchange Ratio”

Shareholders Have A Tough Decision To Make At Mast Therapeutics Inc (NYSEMKT:MSTX)

Insider FinancialRead the rest “Shareholders Have A Tough Decision To Make At Mast Therapeutics Inc (NYSEMKT:MSTX)”

BRIEF-Mast Therapeutics and Savara announce anticipated merger exchange ratio

ReutersRead the rest “BRIEF-Mast Therapeutics and Savara announce anticipated merger exchange ratio”

Mast Therapeutics And Savara Announce Anticipated Merger Exchange Ratio

Yahoo! FinanceRead the rest “Mast Therapeutics And Savara Announce Anticipated Merger Exchange Ratio”

Mast Therapeutics Announces Adjournment Of Special Stockholders Meeting

Yahoo! FinanceRead the rest “Mast Therapeutics Announces Adjournment Of Special Stockholders Meeting”

Mast Therapeutics Announces Possible Adjournment Of Special Stockholders Meeting To Solicit Additional Votes For Merger With Savara

PR NewswireRead the rest “Mast Therapeutics Announces Possible Adjournment Of Special Stockholders Meeting To Solicit Additional Votes For Merger With Savara”

Mast Therapeutics Inc. (NYSEMKT:MSTX) Embraces Savara Inc. as the Best Tactical Strategy

Wall Street PRRead the rest “Mast Therapeutics Inc. (NYSEMKT:MSTX) Embraces Savara Inc. as the Best Tactical Strategy”

BRIEF-Mast reminds stockholders to vote for proposed merger with Savara

ReutersRead the rest “BRIEF-Mast reminds stockholders to vote for proposed merger with Savara”

Mast Reminds Stockholders To Vote For The Proposed Merger With Savara

Yahoo! FinanceRead the rest “Mast Reminds Stockholders To Vote For The Proposed Merger With Savara”

Mast Therapeutics And Savara Announce Approval To List Common Stock On The Nasdaq Capital Market

PR NewswireRead the rest “Mast Therapeutics And Savara Announce Approval To List Common Stock On The Nasdaq Capital Market”

Mast Therapeutics Inc (NYSEMKT:MSTX) Poised For A Turnaround

Insider FinancialRead the rest “Mast Therapeutics Inc (NYSEMKT:MSTX) Poised For A Turnaround”

Mast Therapeutics Sets Date For Special Meeting Of Stockholders To Vote On Proposed Merger With Savara

PR NewswireRead the rest “Mast Therapeutics Sets Date For Special Meeting Of Stockholders To Vote On Proposed Merger With Savara”

Mast Therapeutics, Inc. (NYSEMKT:MSTX) Files An 8-K Regulation FD Disclosure

Market ExclusiveRead the rest “Mast Therapeutics, Inc. (NYSEMKT:MSTX) Files An 8-K Regulation FD Disclosure”

U.S. Patents Awarded to Inventors in Indiana

Targeted News ServiceRead the rest “U.S. Patents Awarded to Inventors in Indiana”

Savara Pharmaceuticals: 2 Biotech Stocks News And Price Trends: Biostage (NASDAQ:BSTG), MAST Therapeutics (NYSEMKT:MSTX)

Voice RegistrarRead the rest “Savara Pharmaceuticals: 2 Biotech Stocks News And Price Trends: Biostage (NASDAQ:BSTG), MAST Therapeutics (NYSEMKT:MSTX)”

Mast Therapeutics, Inc — Bulls & Bears

Seneca GlobeRead the rest “Mast Therapeutics, Inc — Bulls & Bears”

Savara: Time To Put On The Watch List? – MAST Therapeutics, Inc. (NYSEMKT:MSTX)

Voice RegistrarRead the rest “Savara: Time To Put On The Watch List? – MAST Therapeutics, Inc. (NYSEMKT:MSTX)”

Time To Put On The Watch List? – Mast Therapeutics, Inc. 

Voice RegistrarRead the rest “Time To Put On The Watch List? – Mast Therapeutics, Inc. ”

A Glimpse into the Mast Therapeutics Inc (MSTX) and Savara Merger

Smarter AnalystRead the rest “A Glimpse into the Mast Therapeutics Inc (MSTX) and Savara Merger”

Canaccord Cheers Mast Therapeutics Inc (MSTX) In Light Of Strategic Merger With Savara

Smarter AnalystRead the rest “Canaccord Cheers Mast Therapeutics Inc (MSTX) In Light Of Strategic Merger With Savara”

Mast Therapeutics, Inc. (NYSE:MSTX) and Savara Inc entered into definitive merger agreement

Benchmark MonitorRead the rest “Mast Therapeutics, Inc. (NYSE:MSTX) and Savara Inc entered into definitive merger agreement”

Mast Therapeutics Inc (NYSEMKT:MSTX) Signs A Merger Agreement With Savara Inc.

Financial TrendsRead the rest “Mast Therapeutics Inc (NYSEMKT:MSTX) Signs A Merger Agreement With Savara Inc.”

Mast Therapeutics (MSTX) to Merge with Savara

StreetInsider.comRead the rest “Mast Therapeutics (MSTX) to Merge with Savara”

Savara: Another public company is on Austin’s horizon, this time a drugmaker heading for NYSE

Austin Business JournalRead the rest “Savara: Another public company is on Austin’s horizon, this time a drugmaker heading for NYSE”

Mast Therapeutics To Merge With Savara Inc. (MSTX)

InvestopediaRead the rest “Mast Therapeutics To Merge With Savara Inc. (MSTX)”

Mast Therapeutics And Savara Sign Merger Agreement

click hereRead the rest “Mast Therapeutics And Savara Sign Merger Agreement”

Mast Therapeutics And Savara Sign Merger Agreement

click hereRead the rest “Mast Therapeutics And Savara Sign Merger Agreement”

Savara Pharmaceuticals Appoints David L. Lowrance As CFO

click hereRead the rest “Savara Pharmaceuticals Appoints David L. Lowrance As CFO”

Savara Pharmaceuticals Appoints David L. Lowrance As CFO

click hereRead the rest “Savara Pharmaceuticals Appoints David L. Lowrance As CFO”

Savara Builds on Serendex Acquisition by Advancing Inhaled Therapies for Lung Diseases, Infections

click hereRead the rest “Savara Builds on Serendex Acquisition by Advancing Inhaled Therapies for Lung Diseases, Infections”

Savara Fully Acquires Serendex, Readies Phase 3 Trial of Inhaled Antibiotic for CF Lung Infections

click hereRead the rest “Savara Fully Acquires Serendex, Readies Phase 3 Trial of Inhaled Antibiotic for CF Lung Infections”

Savara Completes Acquisition Of Serendex

click hereRead the rest “Savara Completes Acquisition Of Serendex”

Savara Pharmaceuticals Buys Serendex Pharmaceuticals

click hereRead the rest “Savara Pharmaceuticals Buys Serendex Pharmaceuticals”

Austin biotech Savara adds two lung drugs in deal for Serendex

click hereRead the rest “Austin biotech Savara adds two lung drugs in deal for Serendex”

Savara: Austin pharma company makes play for 2 new drugs

click hereRead the rest “Savara: Austin pharma company makes play for 2 new drugs”

Inhaled-Drug Maker Savara Buys European Biotech With Two Candidates

click hereRead the rest “Inhaled-Drug Maker Savara Buys European Biotech With Two Candidates”

Austin’s Savara Pharmaceuticals acquires Denmark firm

click hereRead the rest “Austin’s Savara Pharmaceuticals acquires Denmark firm”

Specialty pharma startup Savara buys up a pair of orphan respiratory candidates

click hereRead the rest “Specialty pharma startup Savara buys up a pair of orphan respiratory candidates”

Savara Pharmaceuticals Acquires Serendex Pharmaceuticals

click hereRead the rest “Savara Pharmaceuticals Acquires Serendex Pharmaceuticals”

Savara Pharma acquires Denmark-based Serendex Pharma

click hereRead the rest “Savara Pharma acquires Denmark-based Serendex Pharma”

Savara Pharmaceuticals Buys Serendex Pharmaceuticals

click hereRead the rest “Savara Pharmaceuticals Buys Serendex Pharmaceuticals”

Austin pharma company Savara makes play for 2 new drugs

click hereRead the rest “Austin pharma company Savara makes play for 2 new drugs”

7 Tips for Raising $39 M from 350 Angels by Rob Neville of Savara

7 TIPS FOR RAISING $39M FROM 350 ANGEL INVESTORS BY ROB NEVILLE OF SAVARA

Rob Neville, CEO of Savara Pharmaceuticals raised over $39M from 350 Angel investors, representing 30 Angel groups from around the world. Neville believes that there are hordes of wealthy individuals looking to invest their money in promising startups.

Read the rest “7 Tips for Raising $39 M from 350 Angels by Rob Neville of Savara”